E-LIB Suche - Ergebnisse für: Bahleda, Rastislav

1

Reactions and adverse events induced by T-cell engagers as ..:

Géraud, Arthur ; Hueso, Thomas ; Laparra, Ariane...
European Journal of Cancer. 205 (2024) - p. 114075 , 2024

Link: https://doi.org/10.1016/..

2

Single-cell multiomics profiling reveals heterogeneous tran..:

Henon, Clémence ; Vibert, Julien ; Eychenne, Thomas...
Cell Reports Medicine. 5 (2024) 6 - p. 101582 , 2024

Link: https://doi.org/10.1016/..

3

Sequence analyses of relapsed or refractory diffuse large B..:

Michot, Jean‐Marie ; Quivoron, Cyril ; Sarkozy, Clémentine...
American Journal of Hematology. 98 (2023) 4 - p. 645-657 , 2023

Link: https://doi.org/10.1002/..

4

Results of an Open-label, Phase Ia/b Study of Pembrolizumab..:

Schöffski, Patrick ; Bahleda, Rastislav ; Wagner, Andrew J....
Clinical Cancer Research. 29 (2023) 17 - p. 3320-3328 , 2023

Link: https://doi.org/10.1158/..

5

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urot..:

Facchinetti, Francesco ; Hollebecque, Antoine ; Braye, Floriane...
Cancer Discovery. 13 (2023) 9 - p. 1998-2011 , 2023

Link: https://doi.org/10.1158/..

6

Safety, recommended dose, efficacy and immune correlates fo..:

Baldini, Capucine ; Danlos, Francois-Xavier ; Varga, Andreea...
Journal of Experimental & Clinical Cancer Research. 41 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

7

Genome-driven medicine for patients with recurrent glioma e..:

Baldini, Capucine ; Younan, Nadia ; Castanon Alvarez, Eduardo...
European Journal of Cancer. 163 (2022) - p. 98-107 , 2022

Link: https://doi.org/10.1016/..

8

Single‐agent gemcitabine in patients with advanced, pre‐tre..:

Watson, Sarah ; Verret, Benjamin ; Ropert, Stanislas...
Cancer Medicine. 12 (2022) 3 - p. 3160-3166 , 2022

Link: https://doi.org/10.1002/..

9

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A..:

Roulleaux Dugage, Matthieu ; Nassif, Elise F. ; Italiano, Antoine.
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

10

Innovative therapies based on molecular orientation in pati..:

Sarkozy, Clémentine ; Michot, Jean‐Marie ; Quivoron, Cyril...
American Journal of Hematology. 96 (2021) 10 - p. , 2021

Link: https://doi.org/10.1002/..

11

Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients..:

Meric-Bernstam, Funda ; Bahleda, Rastislav ; Hierro, Cinta...
Cancer Discovery. 12 (2021) 2 - p. 402-415 , 2021

Link: https://doi.org/10.1158/..

12

Feasibility and first reports of the MATCH-R repeated biops..:

Recondo, Gonzalo ; Mahjoubi, Linda ; Maillard, Aline...
npj Precision Oncology. 4 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

13

Chemotherapy beyond immune checkpoint inhibitors in patient..:

Martin-Romano, Patricia ; Ammari, Samy ; El-Dakdoukti, Yolla...
European Journal of Cancer. 137 (2020) - p. 117-126 , 2020

Link: https://doi.org/10.1016/..

14

Successful treatment with trastuzumab in HER2-positive squa..:

Saleh, Khalil ; Saada, Esma ; Auger, Nathalie...
Oral Oncology. 91 (2019) - p. 129-131 , 2019

Link: https://doi.org/10.1016/..

15

Corrigendum to 'A phase 1b study of afatinib in combination..:

Gazzah, Anas ; Boni, Valentina ; Soria, Jean-Charles...
European Journal of Cancer. 119 (2019) - p. 198 , 2019

Link: https://doi.org/10.1016/..